Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covid-19 Vaccine Protection among Children and Adolescents in Qatar
Hiam Chemaitelly, Sawsan AlMukdad, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 20, pp. 1865-1876
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study
Rosa Morello, Francesco Mariani, Luca Mastrantoni, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101961-101961
Open Access | Times Cited: 89
Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis
Vanessa Piechotta, Waldemar Siemens, Iris Thielemann, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 6, pp. 379-391
Open Access | Times Cited: 51
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature (2025)
Open Access | Times Cited: 2
BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study
Chee Fu Yung, Deanette Pang, Kai‐Qian Kam, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 7, pp. 463-470
Open Access | Times Cited: 25
Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents
Qiong Wu, Jiayi Tong, Bingyu Zhang, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 2, pp. 165-176
Open Access | Times Cited: 13
Vaccination against COVID-19 — risks and benefits in children
Alasdair Munro, Christine E. Jones, Saul N. Faust
European Journal of Pediatrics (2024) Vol. 183, Iss. 3, pp. 1107-1112
Open Access | Times Cited: 9
Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Zhilu Yuan, Zengyang Shao, Lijia Ma, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1994-1994
Open Access | Times Cited: 20
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study
D. Y. Lin, Yangjianchen Xu, Yu Gu, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. 1257-1265
Open Access | Times Cited: 19
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
Lamprini Veneti, Jacob Dag Berild, Sara Viksmoen Watle, et al.
International Journal of Infectious Diseases (2023) Vol. 130, pp. 182-188
Open Access | Times Cited: 16
Current state of COVID-19 in children: 4 years on
Annabel Powell, Alexander C. Dowell, Paul Moss, et al.
Journal of Infection (2024) Vol. 88, Iss. 5, pp. 106134-106134
Open Access | Times Cited: 6
The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis
Wenting Lu, Shuai Zeng, Yuan Yao, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 6
Methodological challenges using routine clinical care data for real-world evidence: a rapid review utilizing a systematic literature search and focus group discussion
Michelle Pfaffenlehner, Max Behrens, Daniela Zöller, et al.
BMC Medical Research Methodology (2025) Vol. 25, Iss. 1
Open Access
Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2–11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population study
María Eugenia Toledo-Romaní, Carmen Valenzuela‐Silva, Minerva Montero-Díaz, et al.
The Lancet Regional Health - Americas (2024) Vol. 34, pp. 100750-100750
Open Access | Times Cited: 3
All-Cause Mortality According to COVID-19 Vaccination Status: an analysis of the UK Office for National Statistics Public Data
Alberto Donzelli, Giovanni Malatesta, Giovanni Di Palmo, et al.
(2023)
Open Access | Times Cited: 9
Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents
Qiong Wu, Bingyu Zhang, Jiayi Tong, et al.
EClinicalMedicine (2024) Vol. 79, pp. 102962-102962
Open Access | Times Cited: 2
COVID-19 Disease in Under-5 Children: Current Status and Strategies for Prevention including Vaccination
Anish Pillai, Anuja Nayak, Deepika Tiwari, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 693-693
Open Access | Times Cited: 7
Risk Factors for Persistent Anosmia and Dysgeusia in Children with SARS-CoV-2 Infection: A Retrospective Study
Francesco Mariani, Rosa Morello, Daniele Omar Traini, et al.
Children (2023) Vol. 10, Iss. 3, pp. 597-597
Open Access | Times Cited: 7
The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial
Napaporn Chantasrisawad, Chonnamet Techasaensiri, Pope Kosalaraksa, et al.
International Journal of Infectious Diseases (2023) Vol. 130, pp. 52-59
Open Access | Times Cited: 5
Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years
Eduardo A. Oliveira, Maria Christina L. Oliveira, Ana Cristina Simões e Silva, et al.
World Journal of Pediatrics (2023) Vol. 19, Iss. 10, pp. 949-960
Open Access | Times Cited: 5
Impact of congenital heart disease on outcomes among pediatric patients hospitalized for COVID-19 infection
Laxmi V. Ghimire, Fu‐Sheng Chou, Othman A. Aljohani, et al.
BMC Pediatrics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Real-world Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents
Qiong Wu, Jiayi Tong, Bingyu Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States
Chad R. Wells, Abhishek Pandey, Seyed M. Moghadas, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 5, pp. 609-617
Closed Access | Times Cited: 1
Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China
Zihao Guo, Ting Zeng, Yaoqin Lu, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
A Review of the Data Supporting Use of COVID-19 Vaccinations in the Pediatric Population
Jeremy S. Stultz, Lea S. Eiland
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 11, pp. 1328-1340
Open Access | Times Cited: 4
Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign
Soha Shawqi Albayat, Muna Almaslamani, Hamad Eid Al‐Romaihi, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 953-953
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top